(A) A description of the policies and procedures of the Department and improvements made by the Department with respect to the following:
(i) How often the Department reviews or inspects patient safety at medical centers of the Department.
(ii) What triggers the aggregated review process at medical centers of the Department.
(iii) What controls the Department has in place for controlled and other high-risk substances, including the following:
(I) Access to such substances by staff.
(II) What medications are dispensed via automation.
(III) What systems are in place to ensure proper matching of the correct medication to the correct patient.
(IV) Controls of items such as medication carts and pill bottles and vials.134 STAT. 1020
(V) Monitoring of the dispensing of medication within medical centers of the Department, including monitoring of unauthorized dispensing.
(iv) How the Department monitors contact between patients and employees of the Department, including how employees are monitored and tracked at medical centers of the Department when entering and exiting the room of a patient.
(v) How comprehensively the Department uses video monitoring systems in medical centers of the Department to enhance patient safety, security, and quality of care.
(vi) How the Department tracks and reports deaths at medical centers of the Department at the local level, Veterans Integrated Service Network level, and national level.
(vii) Procedures.
The procedures of the Department to alert local, regional, and Department-wide leadership when there is a statistically abnormal number of deaths at a medical center of the Department, including—
(I) the manner and frequency in which such alerts are made; and
(II) what is included in such an alert, such as the nature of death and where within the medical center the death occurred.
(viii) Analyses.
The use of root cause analyses with respect to patient deaths in medical centers of the Department, including—
(I) what threshold triggers a root cause analysis for a patient death;
(II) who conducts the root cause analysis; and
(III) how root cause analyses determine whether a patient death is suspicious or not.
(ix) What triggers a patient safety alert, including how many suspicious deaths cause a patient safety alert to be triggered.
(x) The situations in which an autopsy report is ordered for deaths at hospitals of the Department, including an identification of—
(I) when the medical examiner is called to review a patient death; and
(II) the official or officials that decide such a review is necessary.
(xi) The method for family members of a patient who died at a medical center of the Department to request an investigation into that death.
(xii) The opportunities that exist for family members of a patient who died at a medical center of the Department to request an autopsy for that death.
(xiii) The methods in place for employees of the Department to report suspicious deaths at medical centers of the Department.
(xiv) The steps taken by the Department if an employee of the Department is suspected to be implicated in a suspicious death at a medical center of the Department, including—134 STAT. 1021
(I) actions to remove or suspend that individual from patient care or temporarily reassign that individual and the speed at which that action occurs; and
(II) steps taken to ensure that other medical centers of the Department and other non-Department medical centers are aware of the suspected role of the individual in a suspicious death.
(xv) In the case of the suspicious death of an individual while under care at a medical center of the Department, the methods used by the Department to inform the family members of that individual.
(xvi) The policy of the Department for communicating to the public when a suspicious death occurs at a medical center of the Department.
(B) A description of any additional authorities or resources needed from Congress to implement any of the actions, changes to policy, or other matters included in the report required under paragraph (1)